Triple

T22516331
Position Surface form Disambiguated ID Type / Status
Subject voriconazole E556657 entity
Predicate instanceOf P0 FINISHED
Object azole antifungal C46436 CONCEPT FINISHED

How this triple was built (1 step)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

CD Concept disambiguation gpt-5-mini-2025-08-07
Target class: azole antifungal
Context triple: [voriconazole, instanceOf, azole antifungal]
  • A. rifamycin antibiotic
    A rifamycin antibiotic is a bactericidal antimicrobial agent that inhibits bacterial DNA-dependent RNA polymerase, commonly used to treat mycobacterial infections such as tuberculosis and leprosy.
  • B. antiseptic agent
    An antiseptic agent is a substance applied to living tissue to inhibit or destroy microorganisms and prevent infection without causing significant harm to the host.
  • C. antitubercular agent
    An antitubercular agent is a drug used to prevent or treat infections caused by Mycobacterium tuberculosis by inhibiting its growth or killing the bacteria.
  • D. broad-spectrum antibiotic
    A broad-spectrum antibiotic is a drug that can kill or inhibit a wide range of bacterial species, including both Gram-positive and Gram-negative bacteria.
  • E. yeast-like fungus
    A yeast-like fungus is a unicellular or dimorphic fungus that reproduces primarily by budding or fission and often forms creamy, moist colonies resembling those of true yeasts.
  • F. None of above. chosen

Provenance (1 batch)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e5657e881909f16ca58352c50da completed April 16, 2026, 5:37 p.m.
Created at: April 16, 2026, 8:50 p.m.